Project
Project for Potential Osteoarthritis Global Player
Commercialization after Acquisition of US phase 3 dosing completed asset in the territory of "China, Taiwan, Hong Kong and Macau" at first.
- Yes
- None
- Equity
- Bio-Tech
- Technology
- Private Project
- Project Planning
- Financial Services
- Interim Management
- Open for Negotiation
- Professional Services
- 50,000,001 USD or above
- 2,500,001 to 5,000,000 USD
- Market Entry Strategic Analysis
- Private Equity & Venture Capital